Ovarian function during use of Nestorone® subdermal implants-Reference-Cited by-同舟云学术

Ovarian function during use of Nestorone® subdermal implants

Published:2000-03 Issue:3 Volume:61 Page:199-204
ISSN:0010-7824
Container-title:Contraception
language:en
Short-container-title:Contraception

Author:

Brache Vivian,Massai Rebeca,Mishell Daniel R,Moo-Young Alfred J,Alvarez Francisco,Salvatierra Ana Maria,Cochon Leila,Croxatto Horacio,Robbins Ann,Faundes Anibal

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Reproductive Medicine

Reference34 articles.

1. Norplant® consensus statement and background review;Fraser;Contraception,1998

2. Recent experience with and future directions of contraceptive implants and injectable contraceptives;Alvarez-Sanchez;Curr Opin Obstet Gynecol,1993

3. Contraceptive implants;Ladipo;Curr Opin Obstet Gynecol,1994

4. Fertility control with subdermal Silastic capsules containing a new progestin (ST-1435);Coutinho;Int J Fertil,1976

5. Pituitary and ovarian function during contraception with one subcutaneous implant releasing a progestin, ST 1435;Lähteenmäki;Contraception,1982

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nestorone nanosuspension-loaded dissolving microneedles array patch: A promising novel approach for “on-demand” hormonal female-controlled peritcoital contraception;International Journal of Pharmaceutics;2022-02

2. Segesterone acetate serum levels with a regression model of continuous use of the segesterone acetate/ethinyl estradiol contraceptive vaginal system;Contraception;2021-09

3. Pharmacokinetics, metabolism and serum concentrations of progestins used in contraception;Pharmacology & Therapeutics;2021-06

4. A technology evaluation of Annovera: a segesterone acetate and ethinyl estradiol vaginal ring used to prevent pregnancy for up to one year;Expert Opinion on Drug Delivery;2020-05-15

5. Comprehensive overview of the recently FDA-approved contraceptive vaginal ring releasing segesterone acetate and ethinylestradiol: A new year-long, patient controlled, reversible birth control method;Expert Review of Clinical Pharmacology;2019-10-01